260 related articles for article (PubMed ID: 20018850)
1. Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production.
Rodionov RN; Murry DJ; Vaulman SF; Stevens JW; Lentz SR
J Biol Chem; 2010 Feb; 285(8):5385-91. PubMed ID: 20018850
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of alanine-glyoxylate aminotransferase 2 protects from asymmetric dimethylarginine-induced endothelial dysfunction and aortic remodeling.
Rodionov RN; Jarzebska N; Burdin D; Todorov V; Martens-Lobenhoffer J; Hofmann A; Kolouschek A; Cordasic N; Jacobi J; Rubets E; Morawietz H; O'Sullivan JF; Markov AG; Bornstein SR; Hilgers K; Maas R; Pfluecke C; Chen Y; Bode-Böger SM; Hugo CPM; Hohenstein B; Weiss N
Sci Rep; 2022 Jun; 12(1):9381. PubMed ID: 35672381
[TBL] [Abstract][Full Text] [Related]
3. AGXT2 and DDAH-1 genetic variants are highly correlated with serum ADMA and SDMA levels and with incidence of coronary artery disease in Egyptians.
Amir M; Hassanein SI; Abdel Rahman MF; Gad MZ
Mol Biol Rep; 2018 Dec; 45(6):2411-2419. PubMed ID: 30284143
[TBL] [Abstract][Full Text] [Related]
4. Role of alanine:glyoxylate aminotransferase 2 in metabolism of asymmetric dimethylarginine in the settings of asymmetric dimethylarginine overload and bilateral nephrectomy.
Rodionov RN; Martens-Lobenhoffer J; Brilloff S; Hohenstein B; Jarzebska N; Jabs N; Kittel A; Maas R; Weiss N; Bode-Böger SM
Nephrol Dial Transplant; 2014 Nov; 29(11):2035-42. PubMed ID: 25002409
[TBL] [Abstract][Full Text] [Related]
5. Kidney and liver are the main organs of expression of a key metabolic enzyme alanine:glyoxylate aminotransferase 2 in humans.
Jarzebska N; Georgi S; Jabs N; Brilloff S; Maas R; Rodionov RN; Zietz C; Montresor S; Hohenstein B; Weiss N
Atheroscler Suppl; 2019 Dec; 40():106-112. PubMed ID: 31818439
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
[TBL] [Abstract][Full Text] [Related]
7. Probing AGXT2 enzyme activity in mouse tissue by applying stable isotope-labeled asymmetric dimethyl arginine as substrate.
Martens-Lobenhoffer J; Rodionov RN; Bode-Böger SM
J Mass Spectrom; 2012 Dec; 47(12):1594-600. PubMed ID: 23280748
[TBL] [Abstract][Full Text] [Related]
8. Alanine-glyoxylate aminotransferase-2 metabolizes endogenous methylarginines, regulates NO, and controls blood pressure.
Caplin B; Wang Z; Slaviero A; Tomlinson J; Dowsett L; Delahaye M; Salama A; ; Wheeler DC; Leiper J
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2892-900. PubMed ID: 23023372
[TBL] [Abstract][Full Text] [Related]
9. In vivo evidence that Agxt2 can regulate plasma levels of dimethylarginines in mice.
Kittel A; Maas R; König J; Mieth M; Weiss N; Jarzebska N; Hohenstein B; Martens-Lobenhoffer J; Bode-Böger SM; Rodionov RN
Biochem Biophys Res Commun; 2013 Jan; 430(1):84-9. PubMed ID: 23154179
[TBL] [Abstract][Full Text] [Related]
10. Considerable impacts of AGXT2 V140I polymorphism on chronic heart failure in the Chinese population.
Hu XL; Zhou JP; Kuang DB; Qi H; Peng LM; Yang TL; Li X; Zhang W; Zhou HH; Chen XP
Atherosclerosis; 2016 Aug; 251():255-262. PubMed ID: 27423328
[TBL] [Abstract][Full Text] [Related]
11. AGXT2: An unnegligible aminotransferase in cardiovascular and urinary systems.
Hu XL; Li MP; Song PY; Tang J; Chen XP
J Mol Cell Cardiol; 2017 Dec; 113():33-38. PubMed ID: 28970090
[TBL] [Abstract][Full Text] [Related]
12. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
Selley ML
J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
[TBL] [Abstract][Full Text] [Related]
13. Diabetes-linked transcription factor HNF4α regulates metabolism of endogenous methylarginines and β-aminoisobutyric acid by controlling expression of alanine-glyoxylate aminotransferase 2.
Burdin DV; Kolobov AA; Brocker C; Soshnev AA; Samusik N; Demyanov AV; Brilloff S; Jarzebska N; Martens-Lobenhoffer J; Mieth M; Maas R; Bornstein SR; Bode-Böger SM; Gonzalez F; Weiss N; Rodionov RN
Sci Rep; 2016 Oct; 6():35503. PubMed ID: 27752141
[TBL] [Abstract][Full Text] [Related]
14. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
Desai A; Zhao Y; Warren JS
Nephrol Dial Transplant; 2008 May; 23(5):1513-20. PubMed ID: 18204093
[TBL] [Abstract][Full Text] [Related]
15. Alanine-glyoxylate aminotransferase 2 (AGXT2) polymorphisms have considerable impact on methylarginine and β-aminoisobutyrate metabolism in healthy volunteers.
Kittel A; Müller F; König J; Mieth M; Sticht H; Zolk O; Kralj A; Heinrich MR; Fromm MF; Maas R
PLoS One; 2014; 9(2):e88544. PubMed ID: 24586340
[TBL] [Abstract][Full Text] [Related]
16. Effect of asymmetric dimethylarginine (ADMA) on heart failure development.
Liu X; Hou L; Xu D; Chen A; Yang L; Zhuang Y; Xu Y; Fassett JT; Chen Y
Nitric Oxide; 2016 Apr; 54():73-81. PubMed ID: 26923818
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
Dayoub H; Rodionov RN; Lynch C; Cooke JP; Arning E; Bottiglieri T; Lentz SR; Faraci FM
Stroke; 2008 Jan; 39(1):180-4. PubMed ID: 18063827
[TBL] [Abstract][Full Text] [Related]
18. Missense variants of the alanine:glyoxylate aminotransferase 2 gene are not associated with Japanese schizophrenia patients.
Yoshino Y; Abe M; Numata S; Ochi S; Mori Y; Ishimaru T; Kinoshita M; Umehara H; Yamazaki K; Mori T; Ohmori T; Ueno S
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():137-41. PubMed ID: 24727203
[TBL] [Abstract][Full Text] [Related]
19. Genetic variations in the alanine-glyoxylate aminotransferase 2 (AGXT2) gene and dimethylarginines levels in rheumatoid arthritis.
Dimitroulas T; Hodson J; Panoulas VF; Sandoo A; Smith J; Kitas G
Amino Acids; 2017 Jun; 49(6):1133-1141. PubMed ID: 28357606
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthase derangements and hypertension in kidney disease.
Baylis C
Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):1-6. PubMed ID: 22048724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
